| Home > Publications Database > Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives. > Access to Fulltext |
DZNE-2022-00621
|
|||||||
| version 1 |
| ||||||